resveratrol has been researched along with Glucose Intolerance in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (91.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Lu, C; Shu, L; Song, G; Wang, C; Xing, H; Zhao, H | 1 |
| Akter, J; An, HJ; Chun, P; Chung, HY; Jeong, HO; Kim, DH; Kim, MJ; Kim, SJ; Lee, B; Lee, EK; Lee, HJ; Moon, HR; Moon, KM; Ullah, S; Yang, J | 1 |
| Brar, N; Brawerman, GM; Cole, LK; Dolinsky, VW; Doucette, CA; Fonseca, MA; Hatch, GM; Hunt, KL; Kereliuk, SM; Pereira, TJ; Seshadri, N; Xiang, B | 1 |
| Campagnole-Santos, MJ; de Paula, AM; dos Santos, RA; Ferreira, AV; Garcia, ZM; Guimarães, AL; Oliveira Andrade, JM; Paraíso, AF; Santos, SH; Sinisterra, RD; Sousa, FB | 1 |
| Ayer, A; Baron, S; Beaudeux, JL; Bedarida, T; Cottart, CH; Henrion, D; Marchiol, C; Nivet-Antoine, V; Thioulouse, E; Vibert, F | 1 |
| Bae, JW; Hyun, DW; Jung, MJ; Kim, MS; Kim, PS; Lee, J; Shin, NR; Whon, TW; Yun, JH | 1 |
| Ding, S; He, Q; Ji, L; Qi, Z; Xia, J; Xue, X | 1 |
| Chung, JH; Foretz, M; Kang, H; Kim, MK; McBurney, MW; Park, SJ; Um, JH; Viollet, B; Yang, S | 1 |
| Barra, Y; Barthélemy, S; Burcelin, R; Champion, S; Dao, TM; Drucker, DJ; Klopp, P; Pechere, L; Sérée, E; Serino, M; Vachoux, C; Waget, A | 1 |
| Barzilai, N; Cohen, HW; Crandall, JP; Hawkins, M; Kishore, P; Oram, V; Reid, M; Trandafirescu, G | 1 |
| Ahmad, F; Baar, K; Beaven, MA; Brown, AL; Burgin, AB; Chung, JH; Ke, H; Kim, MK; Luo, H; Manganiello, V; Park, SJ; Philp, A; Rehmann, H; Taussig, R; Williams, T | 1 |
| Chen, SJ; Fu, XD; Liu, SP; Mu, PW; Tan, Z; Wang, TH; Zhou, LJ | 1 |
1 trial(s) available for resveratrol and Glucose Intolerance
| Article | Year |
|---|---|
Pilot study of resveratrol in older adults with impaired glucose tolerance.
Topics: Aged; Antioxidants; Blood Glucose; Endothelium, Vascular; Female; Glucose Intolerance; Homeostasis; Humans; Male; Pilot Projects; Resveratrol; Stilbenes | 2012 |
11 other study(ies) available for resveratrol and Glucose Intolerance
| Article | Year |
|---|---|
Effect of resveratrol on intestinal tight junction proteins and the gut microbiome in high-fat diet-fed insulin resistant mice.
Topics: Animals; Bacteria; Diet, High-Fat; Disease Models, Animal; Feces; Firmicutes; Gastrointestinal Microbiome; Gastrointestinal Tract; Glucose Intolerance; Inflammation; Insulin; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; Resveratrol; RNA, Ribosomal, 16S; Tight Junction Proteins | 2020 |
Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice.
Topics: Acetyl-CoA Carboxylase; Animals; Benzoxazoles; Body Weight; Diabetes Mellitus; Enzyme Activators; Fatty Acid Synthases; Fatty Liver; Gene Expression Regulation; Glucose Intolerance; Heterocyclic Compounds, 4 or More Rings; Hypoglycemic Agents; Male; Metabolic Syndrome; Mice, Inbred C57BL; Molecular Docking Simulation; Resveratrol; Sirtuin 1; Sterol Regulatory Element Binding Proteins; Stilbenes | 2018 |
Maternal resveratrol administration protects against gestational diabetes-induced glucose intolerance and islet dysfunction in the rat offspring.
Topics: Animals; Antioxidants; Diabetes, Gestational; Diet, High-Fat; Dietary Sucrose; Female; Glucose; Glucose Intolerance; Homeostasis; Islets of Langerhans; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Resveratrol; Sex Factors | 2019 |
Cross talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice.
Topics: Administration, Oral; Angiotensin I; Animals; Antimetabolites; Cells, Cultured; Diet, High-Fat; Drug Evaluation, Preclinical; Gene Expression; Glucose Intolerance; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Lipolysis; Male; Mice; Obesity; Peptide Fragments; Primary Cell Culture; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Resistin; Resveratrol; Sirtuins; Stilbenes | 2014 |
Resveratrol Decreases TXNIP mRNA and Protein Nuclear Expressions With an Arterial Function Improvement in Old Mice.
Topics: Animals; Aorta; Calcium; Carrier Proteins; Echocardiography, Doppler; Glucose Intolerance; Glucose Tolerance Test; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nuclear Proteins; Oxidative Stress; Phenotype; Random Allocation; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Messenger; Stilbenes; Thioredoxins | 2016 |
Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice.
Topics: Animals; Bacteria; Blood Glucose; Clostridium; Diet, High-Fat; Gastrointestinal Microbiome; Glucose Intolerance; Glucose Tolerance Test; Insulin; Intestines; Lactococcus; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, Inbred C57BL; Obesity; Resveratrol; Signal Transduction; Sirolimus; Stilbenes | 2016 |
Long-term treatment with nicotinamide induces glucose intolerance and skeletal muscle lipotoxicity in normal chow-fed mice: compared to diet-induced obesity.
Topics: Animals; Antioxidants; Autophagy; Diet, High-Fat; Dietary Supplements; Gene Expression Regulation; Glucose Intolerance; Histone Deacetylase Inhibitors; Insulin Resistance; Lipid Metabolism; Male; Mice, Inbred C57BL; Mitophagy; Muscle Proteins; Muscle, Skeletal; Niacinamide; Obesity; Resveratrol; Sirtuin 1; Stilbenes; Time Factors | 2016 |
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol.
Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Drug Resistance; Enzyme Inhibitors; Fibroblasts; Glucose Intolerance; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mitochondria; Muscle, Skeletal; NAD; Resveratrol; Sirtuin 1; Stilbenes; Weight Loss | 2010 |
Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control.
Topics: Animals; Blood Glucose; Dietary Fats; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Intolerance; Inflammation; Intestines; Male; Metagenome; Mice; Mice, Inbred C57BL; Receptors, Glucagon; Resveratrol; Stilbenes; Time Factors | 2011 |
Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipose Tissue, White; Aging; AMP-Activated Protein Kinase Kinases; Animals; Caloric Restriction; Cyclic Nucleotide Phosphodiesterases, Type 4; Diet; Glucose Intolerance; Guanine Nucleotide Exchange Factors; Mice; Models, Molecular; Muscle, Skeletal; NAD; Obesity; Protein Kinases; Resveratrol; Rolipram; Ryanodine Receptor Calcium Release Channel; Signal Transduction; Sirtuin 1; Stilbenes | 2012 |
Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats.
Topics: Animals; Caveolin 3; Cell Membrane; Diet, High-Fat; Estrogen Receptor alpha; Female; Glucose; Glucose Intolerance; Glucose Transporter Type 4; Insulin; Insulin Resistance; Muscle Fibers, Skeletal; Muscle, Skeletal; Ovariectomy; Protective Agents; Protein Transport; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2012 |